In this issue:
Nadofaragene firadenovec gene therapy shows potential for BCG-unresponsive NMIBC
Trial to compare radical cystectomy versus BCG for high-grade NMIBC not feasible
Clinician- versus patient-rated performance status
Whole-pelvic radiation therapy for node-negative high-risk prostate cancer
Cisplatin-based chemotherapy reduces the risk of second TC
Enzalutamide for non-metastatic castration-sensitive prostate cancer
Inter- and intra-tumour heterogeneity of metastatic prostate cancer
Androgen cycling comparable to enzalutamide in post-abiraterone CRPC
Long-term psychological distress in TC patients
FLAME demonstrates a benefit to focal radiotherapy boost in localised prostate cancer
Please login below to download this issue (PDF)